UKCPA: Make CVD prevention your key priority
There are plenty of opportunities for pharmacists to improve the cardiovascular profile of their local area, says Paul Wright, an NHS lead cardiac pharmacist
Nationally, there is a big focus on the prevention of cardiovascular disease (CVD), with the Department of Health and Social Care making this a key priority. There are around 7 million people living with CVD in England, which contributes to 25 per cent of deaths each year. There is also a significant financial implication, with just under £7bn being spent by the NHS each year as a consequence of CVD.
One of the stumbling blocks to preventing CVD is appropriate identification of those at risk.
If a person doesn’t know they have CVD, appropriate primary prevention cannot be initiated. By way of an example, it is suggested that there are 5 million adults with undiagnosed hypertension, and that 30 per cent of patients with atrial fibrillation and 85 per cent of those with familial hypercholesterolaemia are undiagnosed.
Clearly, there is scope for improvement and a number of tools and services to facilitate this are available including:
- NHS Health Checks, if aged between 40 and 74 years
- Asking patients if they know their recent blood pressure readings and offering a blood pressure check if they are unsure
- Asking patients if they have recently had their cholesterol checked and offering testing where appropriate
- Using QRISK tool to assess CVD risk.
Following identification of CVD, appropriate treatment and prevention strategies need to be initiated. Again, local and national data highlight significant opportunities to improve primary prevention. There are 1.6 million patients recorded on GP registers as having hypertension but not being treated to targets of less than 150/90mmHg, with far more not attaining targets of less than 140/90mmHg.
Despite strong evidence for anticoagulation reducing the incidence of stroke in those with AF, just under one in five patients on GP registers with AF and deemed high risk do not receive anticoagulation. It is also estimated that half the adult population with an estimated CVD risk >20 per cent are treated with a statin – the figure for those with a CVD risk >10 per cent being significantly less.
With a quarter of men and women obese and many more overweight, a third of men and over half of women underactive and over 65 per cent consuming excess salt and saturated fat, there is plenty of opportunity to make significant lifestyle interventions and offer useful advice.
For more infomation about the UKCPA access ukclinicalpharmacy.org
This column is produced in association with the UKCPA. The views expressed are those of the author and are not necessarily those of either Pharmacy Magazine or the UKCPA.
Viatris has created this short video based on a publication reviewing global research into the potential impact of the Covid-19 pandemic on mental health. It identifies six areas where psychiatrists can play a role in supporting people's mental health through these difficult times.
Record my learning outcomes
Inspiring stories related to health, fitness and the pursuit of wellbeing
More like this
Learning update: Cracking patients' skin conditions
While the healthcare system’s focus is on tackling the coronavirus pandemic, patients must continue to deal with long-term medical conditions such as chronic skin disorders.
6 Min Article
Applications open for foundation pharmacist training
CPPE has opened applications for the newest intake of pharmacists on its foundation pharmacist training pathway. Limited places are available.
1 Min Article
OTC Omeprazole tablets 20mg: an opportunity for pharmacy
This module highlights a new opportunity to treat heartburn and reflux in the pharmacy with Omeprazole 20mg, which is newly available for customers to purchase OTC.
10 Min Module
Managing hay fever: help meet your customers' needs
This module will improve your hay fever knowledge, helping you to understand its impact on sufferers and recommend the right products to ease symptoms
15 Min Module